RNA-sequencing analysis of umbilical cord plasma microRNAs from healthy newborns

PLoS One. 2018 Dec 3;13(12):e0207952. doi: 10.1371/journal.pone.0207952. eCollection 2018.

Abstract

MicroRNAs are a class of small non-coding RNA that regulate gene expression at a post-transcriptional level. MicroRNAs have been identified in various body fluids under normal conditions and their stability as well as their dysregulation in disease has led to ongoing interest in their diagnostic and prognostic potential. Circulating microRNAs may be valuable predictors of early-life complications such as birth asphyxia or neonatal seizures but there are relatively few data on microRNA content in plasma from healthy babies. Here we performed small RNA-sequencing analysis of plasma processed from umbilical cord blood in a set of healthy newborns. MicroRNA levels in umbilical cord plasma of four male and four female healthy babies, from two different centres were profiled. A total of 1,004 individual microRNAs were identified, which ranged from 426 to 659 per sample, of which 269 microRNAs were common to all eight samples. Many of these microRNAs are highly expressed and consistent with previous studies using other high throughput platforms. While overall microRNA expression did not differ between male and female cord blood plasma, we did detect differentially edited microRNAs in female plasma compared to male. Of note, and consistent with other studies of this type, adenylation and uridylation were the two most prominent forms of editing. Six microRNAs, miR-128-3p, miR-29a-3p, miR-9-5p, miR-218-5p, 204-5p and miR-132-3p were consistently both uridylated and adenylated in female cord blood plasma. These results provide a benchmark for microRNA profiling and biomarker discovery using umbilical cord plasma and can be used as comparative data for future biomarker profiles from complicated births or those with early-life developmental disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Monophosphate / chemistry
  • Biomarkers / blood
  • Biomarkers / chemistry
  • Circulating MicroRNA / blood*
  • Circulating MicroRNA / chemistry
  • Female
  • Fetal Blood / chemistry*
  • Gene Expression Profiling
  • Gene Expression Regulation, Developmental
  • Humans
  • Infant, Newborn / blood*
  • Male
  • RNA Editing
  • Sex Factors
  • Uridine Monophosphate / chemistry

Substances

  • Biomarkers
  • Circulating MicroRNA
  • Adenosine Monophosphate
  • Uridine Monophosphate

Grants and funding

This publication has emanated from research supported in part by research grants from Science Foundation Ireland (SFI) under Grant Numbers SFI/12/RC/2272 (to D.M.M. and G.B.B.), SFI/16/RC/3948, SFI/13/IA/1891, SFI/12/COEN/18, SFI/14/ADV/RC2721 (to D.C.H. and C.M.) and co-funded under the European Regional Development Fund and by FutureNeuro and INFANT industry partners, the Royal College of Surgeons in Ireland seed fund (“PLASMIR-Dx”), the Irish Research Council Epilepsy Ireland/Medical Research Charities Group (to D.C.H.), CURE taking flight, a H2020 Marie Skłowdowksa-Curie Actions Individual Fellowship (Project no. 707530) (to G.P.B.) and EMBL core funding (to D.M.V). The BiHiVE 2 study was funded by the HRB Clinician Scientist Award CSA 2012/40 (to D.M.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.